Investors

  • 2022-08-16
    (1) MAJOR TRANSACTION IN RELATION TO THE TERMINATION AND TRANSITION SERVICES AGREEMENT AND (2) CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
  • 2022-08-12
    Date of Board Meeting
  • 2022-08-04
    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2022
  • 2022-07-12
    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2022
  • 2022-06-29
    AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
  • 2022-06-29
    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON WEDNESDAY, 29 JUNE 2022
  • 2022-06-10
    NEXT DAY DISCLOSURE RETURN
  • 2022-06-07
    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2022
  • 2022-05-25
    2021 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
  • 2022-05-23
    NOTIFICATION LETTER WITH REQUEST FORM TO NON-REGISTERED HOLDERS
 Copyright Everest Medicines 2020  云顶药业(苏州)有限公司 苏ICP备20038571号 |  Terms of Use |  Privacy Policy |  Disclaimers

沪公网安备 31010602006477号